Insmed Incorporated (INSM)

Insmed Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	31,609	37,118	12,351	4,433	2,707	3,224
Market Cap Growth	120.99%	200.52%	178.59%	63.79%	-16.05%	-4.92%
Enterprise Value	31,353	36,178	12,043	4,998	3,023	2,979
Last Close Price	148.61	174.04	69.04	30.99	19.98	27.24
PS Ratio	52.82	61.21	33.96	14.53	11.03	17.11
PB Ratio	43.09	50.23	43.28	-13.36	30.78	7.86
P/TBV Ratio	60.64	70.27	104.23	-	-	13.27
EV/Sales Ratio	51.70	59.66	33.11	16.38	12.32	15.81
Debt / Equity Ratio	1.01	1.01	4.59	-4.09	15.08	1.49
Net Debt / Equity Ratio	-0.92	-0.92	-0.43	-1.74	2.02	-0.38
Net Debt / EBITDA Ratio	0.69	0.69	0.16	-0.87	-0.38	0.44
Net Debt / FCF Ratio	0.70	0.70	0.18	-1.05	-0.43	0.42
Asset Turnover	0.28	0.28	0.22	0.20	0.17	0.19
Inventory Turnover	1.07	1.07	0.94	0.86	0.81	0.76
Quick Ratio	3.35	3.35	4.99	3.64	6.19	5.48
Current Ratio	3.83	3.83	5.45	4.12	6.69	6.19
Return on Equity (ROE)	-249.28%	-249.28%	-	-	-193.22%	-126.66%
Return on Assets (ROA)	-28.99%	-28.99%	-29.30%	-28.50%	-20.61%	-22.50%
Return on Capital Employed (ROCE)	-55.40%	-55.40%	-45.50%	-61.70%	-32.60%	-33.10%
Earnings Yield	-3.99%	-3.44%	-7.40%	-16.91%	-17.79%	-13.48%
FCF Yield	-3.02%	-2.61%	-5.71%	-12.39%	-15.16%	-11.49%
Buyback Yield / Dilution	-21.32%	-21.32%	-16.81%	-14.14%	-9.74%	-14.86%

Updated Feb 19, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q